
About Enveda Therapeutics India Private Limited
Data last updated:
Enveda Therapeutics India Private Limited is a foreign private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Enveda Therapeutics Inc. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 08 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U73100AP2019FTC112638. Its GSTIN is 37AAFCE5951N1Z3 (Andhra Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50.5 Lakh and a paid-up capital of ₹49.63 Lakh. It is led by directors Viswa Teja Saraschandra Srinivasa Colluru and Nookayyasatya Prakasa Krishna Rao Colluru.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 502 Sri Prayaga Residency Mythreyi Nagar Pandurangapuram, Visakhapatnam, Andhra Pradesh, India – 530003.
As per the financials filed for FY 2023, the company reported a revenue of ₹32.77 Cr, a growth of 117% compared to the previous year. For the same year it recorded a net profit of ₹5.69 Cr (net margin 17.3%) and EBITDA of ₹10.91 Cr (EBITDA margin 33.3%). Revenue has grown at a compounded annual rate (CAGR) of 222% over three years.
The company has about 172 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Enveda. The company has 2 deals on record (2 rights issues); the latest was in September 2020.
For more details, the company can be reached via its website envedabio.com.
Company details
Contact details
Enveda Therapeutics India Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is envedabio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address502 Sri Prayaga Residency Mythreyi Nagar Pandurangapuram, Visakhapatnam, Andhra Pradesh, India – 530003
- IndustryTravel and Hospitality, Consumer Professional Services
To see the full contact details of Enveda Therapeutics India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Enveda Therapeutics India operates one associated brand: Enveda. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of AI-based platform to decipher the chemistry of nature and develop new medicines | enveda.com |
Financials of Enveda Therapeutics India Private Limited
FY 2024 filings availableEnveda Therapeutics India Private Limited reported revenue of ₹32.77 Cr (up 117% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 222% over three years, including 117% growth in the latest year. EBITDA rose 143% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹32.77 Cr | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹10.91 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.69 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 33.3% | |||
| Net Profit Margin | 17.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Enveda Therapeutics India Private Limited, buy the company report.
Board of directors of Enveda Therapeutics India Private Limited
Enveda Therapeutics India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Viswa Teja Saraschandra Srinivasa Colluru | Director | 08 Aug 2019 | 7 Years 3 Months | Current |
| Nookayyasatya Prakasa Krishna Rao Colluru | Director | 08 Aug 2019 | 7 Years 3 Months | Current |
Auditor
Enveda Therapeutics India Private Limited is audited by MISTRY & SHAH LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MISTRY & SHAH LLP | FY 2023 | W100683 |
Shareholding
The shareholding of Enveda Therapeutics India Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Enveda Therapeutics India Private Limited, buy the company report.
Deals & funding
Enveda Therapeutics India Private Limited has 2 deals on record (2 rights issues); the latest was in September 2020.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Rights issue | ₹73.9 Lakh | Investors: Enveda Therapeutics Inc. |
| Oct 2019 | Rights issue | ₹24 Lakh | Investors: Enveda Therapeutics Inc. |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Enveda Therapeutics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Enveda Therapeutics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Enveda Therapeutics India Private Limited has a workforce of 172 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 172 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Enveda Therapeutics India Private Limited, buy the company report.
GST
Enveda Therapeutics India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCE5951N1Z3 | Andhra Pradesh | Active | 16 Sep 2019 |
| 36AAFCE5951N1Z5 | Telangana | Active | 13 Jul 2022 |
To see the full GST registrations and return filing status of Enveda Therapeutics India Private Limited, buy the company report.
Recent activity
Enveda Therapeutics India Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Nookayyasatya Prakasa Krishna Rao Colluru was appointed as Director on 08 Aug 2019.
News
Frequently asked questions
Enveda Therapeutics India is an active foreign private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 08 August 2019 (7+ years old) and is registered under CIN U73100AP2019FTC112638.
Enveda Therapeutics India has 2 current directors:
- Viswa Teja Saraschandra Srinivasa Colluru - Director
- Nookayyasatya Prakasa Krishna Rao Colluru - Director
The latest financial statements of Enveda Therapeutics India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Enveda Therapeutics India is 37AAFCE5951N1Z3, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAFCE5951N1Z5 (Telangana).
The CIN (Corporate Identification Number) of Enveda Therapeutics India is U73100AP2019FTC112638. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enveda Therapeutics India was incorporated on 08 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.
Enveda Therapeutics India has 2 deals on record (2 rights issues); the latest was in September 2020.
Nookayyasatya Prakasa Krishna Rao Colluru was appointed as Director on 08 Aug 2019. Viswa Teja Saraschandra Srinivasa Colluru was appointed as Director on 08 Aug 2019.
Enveda Therapeutics India can be reached through the website envedabio.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The registered office of Enveda Therapeutics India is at 502 Sri Prayaga Residency Mythreyi Nagar Pandurangapuram, Visakhapatnam, Andhra Pradesh, India – 530003.

